Wilson Sonsini Goodrich & Rosati advised IonQ on the transaction. IonQ (NYSE: IONQ), a leader in quantum computing, announced that it has reached a definitive agreement...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Insider on the transaction. Insider, a leading AI-native omnichannel experience and customer engagement platform, announced raising $500 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Socure on the transaction. Socure, the leading provider of artificial intelligence for digital identity verification, fraud prevention, and sanction screening,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Stripe on the transaction. Financial infrastructure platform Stripe confirmed that it is acquiring stablecoin infrastructure provider Bridge. The transaction, which...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Featurespace in the deal. Visa (NYSE: V) announced it has signed a definitive agreement to acquire Featurespace, a developer of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
You must be a Standard 1 Year member to access this content.
